Similar articles for PMID: 19116369

Year	Number of Results
1897	1
1947	2
1951	1
1953	1
1954	1
1955	1
1956	1
1957	2
1958	3
1960	1
1962	1
1963	1
1964	1
1967	1
1971	1
1973	1
1974	1
1975	1
1982	1
1994	1
1997	2
1999	3
2000	3
2001	4
2002	9
2003	6
2004	13
2005	24
2006	32
2007	36
2008	64
2009	31
2010	18
2011	20
2012	16
2013	23
2014	23
2015	22
2016	16
2017	11
2018	10
2019	12
2020	13
2021	20
2022	12
2024	0

1

Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?

Ramalho FS, Alfany-Fernandez I, Casillas-Ramirez A, Massip-Salcedo M, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C. Ramalho FS, et al. J Pharmacol Exp Ther. 2009 Apr;329(1):130-40. doi: 10.1124/jpet.108.147835. Epub 2008 Dec 30. J Pharmacol Exp Ther. 2009. PMID: 19116369

2

Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.

Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M, Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C. Casillas-Ramirez A, et al. Crit Care Med. 2008 Apr;36(4):1256-66. doi: 10.1097/CCM.0b013e31816a023c. Crit Care Med. 2008. PMID: 18379253

3

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.

Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M. Cosentino F, et al. Am J Hypertens. 2005 Apr;18(4 Pt 1):493-9. doi: 10.1016/j.amjhyper.2004.11.007. Am J Hypertens. 2005. PMID: 15831358

4

Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.

Calò LA, Schiavo S, Davis PA, Pagnin E, Mormino P, D'Angelo A, Pessina AC. Calò LA, et al. J Hypertens. 2010 Jan;28(1):111-8. doi: 10.1097/HJH.0b013e328332b738. J Hypertens. 2010. PMID: 19797979

5

Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion.

Elias-Miró M, Massip-Salcedo M, Raila J, Schweigert F, Mendes-Braz M, Ramalho F, Jiménez-Castro MB, Casillas-Ramírez A, Bermudo R, Rimola A, Rodes J, Peralta C. Elias-Miró M, et al. Liver Transpl. 2012 Oct;18(10):1198-208. doi: 10.1002/lt.23489. Liver Transpl. 2012. PMID: 22685091 Free article.

6

Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation.

Padrissa-Altés S, Franco-Gou R, Boillot O, Serafín A, Rimola A, Arroyo V, Rodés J, Peralta C, Roselló-Catafau J. Padrissa-Altés S, et al. Liver Transpl. 2009 Mar;15(3):313-20. doi: 10.1002/lt.21693. Liver Transpl. 2009. PMID: 19242996 Free article.

7

Preservation of steatotic livers in IGL-1 solution.

Ben Mosbah I, Roselló-Catafau J, Franco-Gou R, Abdennebi HB, Saidane D, Ramella-Virieux S, Boillot O, Peralta C. Ben Mosbah I, et al. Liver Transpl. 2006 Aug;12(8):1215-23. doi: 10.1002/lt.20788. Liver Transpl. 2006. PMID: 16724331 Free article.

8

Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers.

Ben Mosbah I, Massip-Salcedo M, Fernández-Monteiro I, Xaus C, Bartrons R, Boillot O, Roselló-Catafau J, Peralta C. Ben Mosbah I, et al. Liver Transpl. 2007 Mar;13(3):410-25. doi: 10.1002/lt.21059. Liver Transpl. 2007. PMID: 17326058 Free article.

9

Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury.

Zaoualí MA, Reiter RJ, Padrissa-Altés S, Boncompagni E, García JJ, Ben Abnennebi H, Freitas I, García-Gil FA, Rosello-Catafau J. Zaoualí MA, et al. J Pineal Res. 2011 Mar;50(2):213-21. doi: 10.1111/j.1600-079X.2010.00831.x. Epub 2010 Nov 25. J Pineal Res. 2011. PMID: 21108657

10

Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.

Sasaoka T, Egi Y, Tawa M, Yamamoto A, Ohkita M, Takaoka M, Maruyama T, Akira T, Matsumura Y. Sasaoka T, et al. J Cardiovasc Pharmacol. 2008 Aug;52(2):176-83. doi: 10.1097/FJC.0b013e31818127f8. J Cardiovasc Pharmacol. 2008. PMID: 18670361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

418 results

Results by year